← Leaderboards
Yael R Hirsch-Moverman
Columbia University Health Sciences
$2,523,371
Attributed
$2,650,119
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $400.6K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,650,119 · 7
By mechanism
R21$2,014,987 · 6
K01$635,132 · 1
Top collaborators
- Max O'Donnell1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Wafaa M. El-Sadr$1,113,559,119
- Donna R Shelley$27,358,680
- Wan Yang$5,140,663
- Scott M Hammer$126,273,157
- Elaine Janine Abrams$67,853,604
Others in their field
Top investigators on “Services”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,236,423,805
- Leonard Freedman · Leidos Biomedical Research, Inc.$868,224,440
- Larry Arthur$689,089,782
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
ServicesTuberculosisProgramsIncidencePersonsCountryInterviewPreventionHealth PersonnelRecommendationPrevalenceCommunitiesCaringAdultChildInformantHigh RiskEvaluationIsoniazidDesignHealth Care FacilityFundingPreferenceCause Of Death
Grant awards (18)
Mobilizing Innovative Strategies to Improve TB Diagnosis and Retention in the TB Care Cascade for Migrant Communities in New York City$253,497
R21 · FY2025 · AI
Rifapentine in High Doses in Pregnancy with TB (Radiant-Moms) study$72,598
R21 · FY2025 · AI · contact PI
Rifapentine in High Doses in Pregnancy with TB (Radiant-Moms) study$38,977
R21 · FY2025 · AI · contact PI
Rifapentine in High Doses in Pregnancy with TB (Radiant-Moms) study$35,505
R21 · FY2025 · AI · contact PI
Rifapentine in High Doses in Pregnancy with TB (Radiant-Moms) study$166,541
R21 · FY2024 · AI · contact PI
Promoting HIV Testing and Linkage to Care in Cross-Border Migrants in Lesotho$164,551
R21 · FY2023 · MH · contact PI
Promoting HIV Testing and Linkage to Care in Cross-Border Migrants in Lesotho$196,051
R21 · FY2022 · MH · contact PI
Diabetes Evaluation in TB Patients in Eswatini for Improving TB/HIV Care and Treatment (DETECT) Study$163,159
R21 · FY2022 · AI · contact PI
Diabetes Evaluation in TB Patients in Eswatini for Improving TB/HIV Care and Treatment (DETECT) Study$201,492
R21 · FY2021 · AI · contact PI
Flexible InteRvention Strategy for TB prevention (FIRST) study$164,884
R21 · FY2021 · AI · contact PI
Flexible InteRvention Strategy for TB prevention (FIRST) study$195,412
R21 · FY2020 · AI · contact PI
PRovide Options for Treatment of Exposed Children against Tuberculosis (PROTECT) Study$164,000
R21 · FY2019 · AI · contact PI
PRovide Options for Treatment of Exposed Children against Tuberculosis (PROTECT) Study$198,320
R21 · FY2018 · AI · contact PI
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)$127,860
K01 · FY2018 · AI · contact PI
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)$127,788
K01 · FY2017 · AI · contact PI
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)$123,619
K01 · FY2016 · AI · contact PI
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)$128,016
K01 · FY2015 · AI · contact PI
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)$127,849
K01 · FY2014 · AI · contact PI